Skip to main content
. 2020 Jul 30;106(7):1892–1901. doi: 10.3324/haematol.2020.253781

Figure 4.

Figure 4.

Eppstein-Barr virus DNA levels in the whole blood and plasma after treatment with ruxolitinib. Reported Eppstein-Barr virus (EBV) DNA values are limited to 500 copies/L by the clinical laboratory. The dotted line on the x-axis of each graph indicate the start of RUX treatment.